The application of embryonic stem cells to study motor neurone disease: exploring models mechanisms and therapy

Lead Research Organisation: King's College London
Department Name: Unlisted

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Publications

10 25 50
 
Description Sumission to Parliamentary Science and Technology Committee
Geographic Reach National 
Policy Influence Type Gave evidence to a government review
Impact Permitted the use of hybrid embryos in research in UK
 
Description King's Biomedical Sciences Institute PhD Studentship
Amount £100,000 (GBP)
Organisation King's College London 
Sector Academic/University
Country United Kingdom
Start 03/2014 
End 10/2017
 
Description MNDA studentship
Amount £87,502 (GBP)
Organisation Motor Neurone Disease Association (MND) 
Sector Charity/Non Profit
Country United Kingdom
Start 10/2010 
End 09/2013
 
Description MRC Case Studentship
Amount £100,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Academic/University
Country United Kingdom
Start 10/2014 
End 10/2018
 
Description Project grant
Amount £493,407 (GBP)
Organisation Motor Neurone Disease Association (MND) 
Sector Charity/Non Profit
Country United Kingdom
Start 10/2015 
End 09/2018
 
Description Studentship
Amount £250,000 (GBP)
Organisation British Society for the History of Science (BSHS) 
Department Darwin Trust of Edinburgh
Sector Academic/University
Country United Kingdom
Start 09/2014 
End 09/2017
 
Description From ALS exomes to Functional assays: turning candidates into confirmed genes 
Organisation Medical Research Council (MRC)
Department Medical Research Foundation
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Scientific expertise on ALS pathogenesis
Collaborator Contribution financial support
Impact None yet as started 5 months ago
Start Year 2015
 
Description Generation and characterisation of induced pluripotent stem cells from ALS lymphoblasts to model disease pathogenesis and advance drug discovery 
Organisation Motor Neurone Disease Association (MND)
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Research excellence
Collaborator Contribution Financial and access to lymphoblast cell lines
Impact Nil yet as just started
Start Year 2015
 
Description Identification of compounds that enhance TDP43 clearance in ALS and FTD 
Organisation Eli Lilly & Company Ltd
Department Neuroscience Eli Lilly
Country United States 
Sector Private 
PI Contribution Identify therapeutic targets for drug discovery
Collaborator Contribution Expertise in drug discovery
Impact About to start
Start Year 2016
 
Description Investigating the role of autophagy and the UPS in TDP-ALS 
Organisation Motor Neurone Disease Association (MND)
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution ALS pathobiology
Collaborator Contribution Financial Support
Impact None
Start Year 2015
 
Description Vertex Pharmaceutical 
Organisation Vertex Pharmaceuticals
Country United States 
Sector Private 
PI Contribution Developing a cellular screening platform to identify small molecule correctors of the TDP-43 pathology
Collaborator Contribution Funding to develop Cellular assay for high throughout screening
Impact None so far
Start Year 2013
 
Description MRC Centre Open Day 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Primary Audience Participants in your research and patient groups
Results and Impact Our Open Day is for patients and carers with approximately 150 attendees. We organise 8 laboratory demonstrations presented by PhD students and postdoctoral researchers around which small groups (6-8 persons) circulate. We also have a group of about 12 sixth form students who perform a laboratory experiment. At the end of the day the sixth formers present their results to the who audience and this is followed by an "Any Questions" session with clinical and non-clinical experts answering questions from the visitors.

The Open Day has now been run on three occasions and each time has received universal acclaim from visitors. The report is also made available on our web site.
Year(s) Of Engagement Activity 2008
 
Description Many media interviews TV, Radio, Newspapers, Radio 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Primary Audience Public/other audiences
Results and Impact Many media interviews TV, Radio, Newspapers, Radio

Legislation modified
Year(s) Of Engagement Activity 2008
 
Description Multi-site Phosphorylation Assays for Tau Protein and their relevance to Alzheimer's disease and other neurological disorders 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Primary Audience Participants in your research and patient groups
Results and Impact Poster presentation at American Society of Mass Spectrometry conference

None
Year(s) Of Engagement Activity 2008
 
Description Patient and Carers meeting 
Form Of Engagement Activity A formal working group, expert panel or dialogue
Part Of Official Scheme? No
Primary Audience Participants in your research and patient groups
Results and Impact 40-60 Patients and Carers lasting 1.5 hours of talk and discussion

Members of the audience are fundraising for a studentship for my laboratory
Year(s) Of Engagement Activity 2006,2007,2008,2009,2010
 
Description Patient and Carers meeting 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? Yes
Primary Audience Participants in your research and patient groups
Results and Impact Each meeting has 40-60 attendees and lasts 1.5 hours with talk and questions

Patients have come to our laboratory open day and are actively fundraising to create a studentship
Year(s) Of Engagement Activity 2006,2007,2008,2009,2010
 
Description Presented to Members of Parliament 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Primary Audience Policymakers/politicians
Results and Impact Presented to parliamentary parties

Legeislation changed
Year(s) Of Engagement Activity 2008
 
Description Public lecture 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact Public lecture on the genetics and biology of motor neuron disease
Year(s) Of Engagement Activity 2016
 
Description Public lecture on motor neuron disease research 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Supporters
Results and Impact I spoke at a dinner hosted by the MND Association for major donors at the Royal Institution
Year(s) Of Engagement Activity 2016
 
Description School visit Peterborough 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Primary Audience Schools
Results and Impact Lectured to school students and informal chat

Enthusiastic discussion
Year(s) Of Engagement Activity 2006
 
Description Sleep and circadian rhythm disorder in Parkinson's Disease: association with hallucinations 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Primary Audience Participants in your research and patient groups
Results and Impact A world conference on sleep.

Received a citation award.
Year(s) Of Engagement Activity 2007
 
Description The Use of Mass Spectrometry for Multi-site Phosphorylation Assays for Tau Protein 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Primary Audience Participants in your research and patient groups
Results and Impact Poster presentation at International Conference on Alzheimer's Disease, Chicago

None
Year(s) Of Engagement Activity 2008